Small scale rat hepatocyte primary culture with applications for screening hepatoprotective substances

Bioscience, Biotechnology and Biochemistry

Volumn 67, Issue 8, 2003, Pages 1629-1635

  Nakagiri, Ryusuke ^a   Oda, Hiroaki ^b   Kamiya, Toshikazu ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Acetaminophen; D galactosamine; Hepatocyte; Hepatoprotective; Screening

Indexed keywords

COLLAGEN; DEXAMETHASONE; GALACTOSAMINE; INSULIN; LAMININ; MATRIGEL; PARACETAMOL; PLANT EXTRACT; PROTEOGLYCAN;

ANIMAL; ARTICLE; CELL SURVIVAL; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; DRUG SCREENING; GLYCYRRHIZA; LIVER; LIVER CELL; MALE; METABOLISM; METHODOLOGY; PATHOLOGY; RAT; SCHISANDRACEAE; SPRAGUE DAWLEY RAT;

ACETAMINOPHEN; ANIMALS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; COLLAGEN; DEXAMETHASONE; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; GALACTOSAMINE; GLYCYRRHIZA; HEPATOCYTES; INSULIN; LAMININ; LIVER; MALE; PLANT EXTRACTS; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; SCHISANDRA;

GLYCYRRHIZA; GLYCYRRHIZA GLABRA; SCHISANDRA; SCHISANDRA CHINENSIS; SCHISANDRACEAE;

EID: 0942286026     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.67.1629     Document Type: Article

References (20)

1. Oda, H., Nozawa, K., Hitomi, Y., and Kakinuma, A., Laminin-rich extracellular matrix maintains high level of hepatocyte nuclear factor 4 in rat hepatocyte culture. Biochem. Biophys. Res. Commun., 212, 800-805 (1995).
2. Caron, J. M., Induction of albumin gene transcription in hepatocytes by extracellular matrix proteins. Mol. Cell. Biol., 10, 1239-1243 (1990).
3. Brown, S. E., Guzelian, C. P., Schuetz, E., Quattrochi, L. C., Kleinman, H. K., and Guzelian, P. S., Critical role of extracellular matrix on induction by phenobarbital of cytochrome P450 2B1 /2 in primary cultures of adult rat hepatocytes. Lab. Invest., 73, 818-827 (1995).
4. Oda, H., Cell shape regulates liver-differentiation through HNF-4 in hepatocyte. Nippon Nogeikagaku Kaishi (in Japanese), 70, 797-798 (1996).
5. Musat, A. I., Sattler, C. A., Sattler, G. L., and Pitot, H. C., Reestablishment of cell polarity of rat hepatocytes in primary culture. Hepatology, 18, 198-205 (1993).
6. Seglen, P. O., Preparation of isolated rat liver cells. Methods Cell. Biol., 13, 29-83 (1976).
7. Rollins, D. E., von Bahr, C., Glaumann, H., Moldeus, P., and Rane, A., Acetaminophen: potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells. Science, 205, 1414-1416 (1979).
8. Buttar, H. S., Nera, E. A., and Downie, R. H., Serum enzyme activities and hepatic triglyceride levels in acute and subacute acetaminophen-treated rats. Toxicology, 6, 9-20 (1976).
9. Schanne, F. A., Zucker, A. H., Farber, J. L., and Rubin, E., Alcohol-dependent liver cell necrosis in vitro: a new model. Science, 212, 338-340 (1981).
10. Lesch, R., Reutter, W., Keppler, D., and Decker, K., Liver restitution after acute galactosamine hepatitis: autoradiographic and biochemical studies in rats. Exp. Mol. Pathol., 12, 58-69 (1970).
11. Koul, I. B., and Kapil, A., Evaluation of the liver protective potential of piperine, an active principle of black and long peppers. Planta Med., 59, 413-417 (1993).
12. Matsuda, H., Ninomiya, K., Morikawa, T., and Yoshikawa, M., Inhibitory effect and action mechanism of sesquiterpenes from Zedoariae Rhizoma on d-galactosamine/lipopolysaccharide-induced liver injury. Bioorg. Med. Chem., 8, 339-344 (1998).
13. Ohta, S., Suzuki, M., Sato, N., Kamogawa, A., and Shinoda, M., Protective effects of sesamol and its related compounds on carbon tetrachloride induced liver injury in rats. Yakugaku Zasshi (in Japanese), 114, 901-910 (1994).
14. Reen, R. K., and Singh, J., In vitro and in vivo inhibition of pulmonary cytochrome P450 activities by piperine, a major ingredient of Piper species. Indian. J. Exp. Biol., 29, 568-573 (1991).
15. Soni, K. B., Lahiri, M., Chackradeo, P., Bhide, S. V., and Kuttan, R., Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocar-cinogenicity. Cancer Lett., 115, 129-133 (1997).
16. Maeda, S., Sudo, K., Miyamoto, Y., Takeda, S., Shinbo, M., Aburada, M., Ikeya, Y., Taguchi, H., and Harada, M., Pharmacological studies on schizan-dra fruits. II. Effects of constituents of shizandra fruits on drugs induced hepatic damage in rats. Yakugaku Zasshi (in Japanese), 102, 579-588 (1982).
17. Takeda, S., Funo, S., Iizuka, A., Kase, Y., Arai, I., Ohkura, Y., Sudo, K., Kiuchi, N., Yoshida, C., and Maeda, S., Pharmacological studies on schizandra fruits. III. Effects of wuweizisu C, a lignan component of schizandra fruits, on experimental liver injuries in rats. Nippon Yakurigaku Zasshi (in Japanese), 85, 193-208 (1985).
18. Acharya, S. K., Dasarathy, S., Tandon, A., Joshi, Y. K., and Tandon, B. N., A preliminary open trial on interferon stimulator (SNMC) derived from Glycyr-rhiza glabra in the treatment of subacute hepatic failure. Indian. J. Med. Res., 98, 69-74 (1993).
19. Moon, A., and Kim, S. H., Effect of Glycyrrhiza glabra roots and glycyrrhizin on the glucuronidation in rats. Planta Med., 63, 115-119 (1997).
20. Luper, S., A review of plants used in the treatment of liver disease: part two. Alt. Med. Rev., 4, 178-188 (1999).